组别 | UCLA | ASES | CMS | VAS | ||||
治疗前 | 治疗后 | 治疗前 | 治疗后 | 治疗前 | 治疗后 | 治疗前 | 治疗后 | |
观察组(n = 33) | 11.45 ± 2.44 | 32.09 ± 3.34 | 51.77 ± 5.34 | 92.67 ± 4.43 | 50.76 ± 4.25 | 88.56 ± 5.47 | 7.22 ± 2.01 | 1.25 ± 0.21 |
对照组(n = 34) | 11.14 ± 2.13 | 25.88 ± 3.57 | 51.66 ± 5.13 | 82.56 ± 5.33 | 50.34 ± 4.12 | 80.14 ± 5.22 | 6.34 ± 2.11 | 3.09 ± 0.23 |
t | 0.033 | 2.346 | 0.621 | 2.784 | 0.898 | 3.081 | 0.944 | 4.097 |
P | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 |